Ade2 Auxotrophic Yeast Strains for Stable Multi-Copy Protein Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for protein production in Pichia pastoris yeast struggle with achieving high cellular productivity and stability of recombinant protein expression, particularly due to issues with single-crossover integration and the toxicity of proteins to host cells, leading to challenges during fermentation and selection of multi-copy integrants.
Innovation Solution
The development of slower-growing ade2 auxotrophic strains and integration vectors with an ADE2 marker gene operably linked to a weak promoter, allowing for multi-copy integration and stable expression of recombinant proteins by rendering the cells prototrophic for adenine, thereby selecting for cells with multiple integration vector copies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If single-crossover integration is used to integrate expression vectors into the Pichia pastoris genome, then transformation is simplified, but multiple integrated copies collapse back into a single copy through homologous recombination, reducing protein expression levels
Solution Approach 1:
The patent extracts the problematic homologous recombination mechanism that causes copy collapse and replaces it with a non-homologous integration method. By using a vector with a unique integration site and a selection marker that confers resistance to a drug not present in the wild-type genome, the system achieves stable multi-copy integration without the collapsing recombination that plagues conventional single-crossover methods.
Solution Approach 2:
The patent introduces an intermediary selection mechanism (drug resistance marker) that mediates the selection of multi-copy integrants. This marker acts as a mediator to distinguish cells with multiple expression vector copies from those with single copies, enabling stable maintenance of high copy numbers through selective pressure rather than relying on homologous recombination.
2Quantity of substance
If drug resistance genes are used as selection markers to increase the number of transformants with multiple copies, then protein expression levels improve, but the complexity of the selection system increases and cell growth is affected
Solution Approach 1:
The patent changes the selection parameter from conventional drug resistance markers to a novel marker system based on adenine biosynthesis (ADE2). This parameter change allows for simpler selection chemistry and reduces the metabolic burden on cells, as the ADE2 marker provides a more straightforward selection mechanism that doesn't require complex drug resistance cascades.
3Productivity
If multiple copies of the expression vector are integrated into the genome to increase protein expression, then productivity improves, but the stability of protein expression decreases due to homologous recombination and copy collapse
Solution Approach 1:
The patent applies preliminary action by pre-establishing a genomic locus with a unique integration site and pre-configuring the expression vector with corresponding homology arms. This preliminary setup ensures that integration occurs at the predetermined location without subsequent homologous recombination events, thereby stabilizing multi-copy integration and maintaining consistent protein expression levels over time.
4Productivity
If conventional selection markers are used to select for multi-copy integrants, then high protein expression can be achieved, but the toxicity of recombinant proteins to host cells exacerbates the difficulty of maintaining stable expression
Solution Approach 1:
The patent converts the harmful effect of protein toxicity into a beneficial selection pressure. By using the ADE2 marker system, cells that maintain multiple expression vector copies (and thus produce toxic recombinant proteins) are selected for their ability to survive on adenine-deficient media. The toxicity that would normally be detrimental becomes a marker for successful multi-copy integration and stable expression.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the production of higher quantities of recombinant proteins by ensuring multiple copies of the integration vector are integrated into the genome, maintaining protein expression stability and facilitating the selection of cells with enhanced productivity, even in the presence of toxic proteins.
Implementation Method 1
the integration vector integrates into the genome of the ade2 auxotrophic strain
Implementation Method 2
the ADE2 renders the auxotrophic strain prototrophic for adenine
Implementation Method 3
ADE2 marker gene operably linked to a weak promoter
Data Source
Figure 1
Figure 2A
Figure 2B
AI summary
Method and system for expression systems, based on ade1 and ade2 auxotrophic strains of yeast and fungi, including P. pastoris are disclosed. The expression systems are useful for increased cellular productivity of transformed cell lines and for production of recombinant glycoproteins at industrial scale.